Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Guang’an
Clinical trial register · China

Clinical Trials in Guang’an, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19257 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:17 UTC
19257
Studies in scope
all four open statuses
11829
Recruiting now
open to new participants
2031
Lead sponsors
across recruiting studies
Top sites
Beijing 5598 Shanghai 3888 Guangzhou 3358 Hangzhou 1831 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC1
Site location
Beijing5598 Shanghai3888 Guangzhou3358 Hangzhou1831 Wuhan1343 Chengdu1309 Nanjing1213 Changsha1159 Chongqing1083 Fuzhou1042 Tianjin939 Zhengzhou928 Hefei906 Jinan791 Changchun640 Shenzhen585 Harbin549 Nanchang449 Xi'an443 Nanning442 Suzhou431 Shenyang406 Xiamen392 Shijiazhuang351 Lanzhou273 Show all 624
All 624 locations
Target enrolment
to

Trials with a site in Guang’an

1 of 19257 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,590
Liuzhou, Louxing District, Guang’an, Mianyang
2022-05-07
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-china/city/guang-an

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,257 studies in total at the last sync on 13 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Guang’an.

How many clinical trials are recruiting in Guang’an?

0 of the 1 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Guang’an), 1 studies
PhaseStudiesRecruitingShare
Phase 310100%

Most active sponsors

Lead sponsors with the most studies (Guang’an)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.